Detecting new neurodegenerative disease genes: does phenotype accuracy limit the horizon?

Trends in Genetics

Volumn 25, Issue 11, 2009, Pages 486-488

  Samuels, David C ^a   Burn, David J ^b,c   Chinnery, Patrick F ^c  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

^c NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E4; IODINE 123 2BETA CARBOMETOXY 3BETA(4 IODOPHENYL) N (3 FLUOROPROPYL)NORTROPANE I 123; RADIOLIGAND; UNCLASSIFIED DRUG;

ALLELE; ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; AUTOPSY; CLINICAL CLASSIFICATION; DEGENERATIVE DISEASE; DEMENTIA; DIAGNOSTIC ACCURACY; DIAGNOSTIC ERROR; DIFFERENTIAL DIAGNOSIS; GENE FREQUENCY; GENETIC ANALYSIS; GENETIC RISK; GENETIC VARIABILITY; HEREDITY; HUMAN; LETTER; PARKINSON DISEASE; PARKINSONISM; PHENOTYPE; PHENOTYPE ACCURACY; POWER ANALYSIS; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; RARE DISEASE; SENSITIVITY AND SPECIFICITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

GENOME, HUMAN; GENOME-WIDE ASSOCIATION STUDY; HUMANS; NEURODEGENERATIVE DISEASES; PHENOTYPE;

EID: 70350351582     PISSN: 01689525     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tig.2009.09.008     Document Type: Letter

References (14)

1. Hardy J., and Singleton A. Genomewide association studies and human disease. N. Engl. J. Med. 360 (2009) 1759-1768
2. Lansbury Jr. P.T. Back to the future: the 'old-fashioned' way to new medications for neurodegeneration. Nat. Med. 10 Suppl. (2004) S51-S57
3. Hughes A.J., et al. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J. Neurol. Neurosurg. Psychiatry 55 (1992) 181-184
4. Hughes A.J., et al. The accuracy of diagnosis of parkinsonian syndromes in a specialist movement disorder service. Brain 125 (2002) 861-870
5. Caslake R., et al. Changes in diagnosis with follow-up in an incident cohort of patients with parkinsonism. J. Neurol. Neurosurg. Psychiatry 79 (2008) 1202-1207
6. Bross I. Misclassification in 2 × 2 tables. Biometrics 10 (1954) 478-486
7. Gordon D., et al. Increasing power for tests of genetic association in the presence of phenotype and/or genotype error by use of double-sampling. Stat. Appl. Genet. Mol. Biol. 3 (2004) Article 26
8. Gordon D. Gene mapping: balance among quality, quantity and cost of data in the era of whole-genome mapping for complex disease. Eur. J. Hum. Genet. 14 (2006) 1147-1148
9. Brzustowicz L.M., and Bassett A.S. Phenotype matters: the case for careful characterization of relevant traits. Am. J. Psychiatry 165 (2008) 1096-1098
10. Edwards B.J., et al. Power and sample size calculations in the presence of phenotype errors for case/control genetic association studies. BMC Genet. 6 (2005) 18
11. Altshuler D., and Daly M. Guilt beyond a reasonable doubt. Nat. Genet. 39 (2007) 813-815
12. Marshall V.L., et al. Parkinson's disease is overdiagnosed clinically at baseline in diagnostically uncertain cases: A 3-year European multicenter study with repeat [(123)I]FP-CIT SPECT. Mov. Disord. 24 (2008) 499-507
13. McKeith I., et al. Sensitivity and specificity of dopamine transporter imaging with 123I-FP-CIT SPECT in dementia with Lewy bodies: a phase III, multicentre study. Lancet Neurol. 6 (2007) 305-313
14. Sawcer S. The complex genetics of multiple sclerosis: pitfalls and prospects. Brain 131 (2008) 3118-3131